The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease.
Saved in:
| Title: | The Safety Profile of Pridopidine, a Novel Sigma-1 Receptor Agonist for the Treatment of Huntington's Disease. |
|---|---|
| Authors: | Goldberg YP; Prilenia Therapeutics B.V., Naarden, The Netherlands., Navon-Perry L; Prilenia Therapeutics B.V., Naarden, The Netherlands., Cruz-Herranz A; Prilenia Therapeutics B.V., Naarden, The Netherlands., Chen K; Prilenia Therapeutics B.V., Naarden, The Netherlands., Hecker-Barth G; GHB Hecker-Barth Biopharma Consulting GmbH, Konstanz, Germany., Spiegel K; Prilenia Therapeutics B.V., Naarden, The Netherlands., Cohen Y; Prilenia Therapeutics B.V., Naarden, The Netherlands., Niethammer M; North Shore University Hospital, Northwell Health, Manhasset, NY, USA., Tan AM; Prilenia Therapeutics B.V., Naarden, The Netherlands.; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA., Schuring H; Prilenia Therapeutics B.V., Naarden, The Netherlands., Geva M; Prilenia Therapeutics B.V., Naarden, The Netherlands., Hayden MR; Prilenia Therapeutics B.V., Naarden, The Netherlands. Michael.Hayden@prilenia.com.; Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, V5Z 4H4, Canada. Michael.Hayden@prilenia.com. |
| Source: | CNS drugs [CNS Drugs] 2025 May; Vol. 39 (5), pp. 485-498. Date of Electronic Publication: 2025 Mar 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1934 |
|---|---|
| DOI: | 10.1007/s40263-025-01171-x |
